313 related articles for article (PubMed ID: 31461640)
21. Differential expression and pharmacology of native P2X receptors in rat and primate sensory neurons.
Serrano A; Mo G; Grant R; Paré M; O'Donnell D; Yu XH; Tomaszewski MJ; Perkins MN; Séguéla P; Cao CQ
J Neurosci; 2012 Aug; 32(34):11890-6. PubMed ID: 22915129
[TBL] [Abstract][Full Text] [Related]
22. Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+.
Li M; Silberberg SD; Swartz KJ
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3455-63. PubMed ID: 23959888
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
24. Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.
Mo G; Bernier LP; Zhao Q; Chabot-Doré AJ; Ase AR; Logothetis D; Cao CQ; Séguéla P
Mol Pain; 2009 Aug; 5():47. PubMed ID: 19671169
[TBL] [Abstract][Full Text] [Related]
25. Blockage of HCN Channels Inhibits the Function of P2X Receptors in Rat Dorsal Root Ganglion Neurons.
Lei X; Zeng J; Yan Y; Liu X
Neurochem Res; 2022 Apr; 47(4):1083-1096. PubMed ID: 35064517
[TBL] [Abstract][Full Text] [Related]
26. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
Gever JR; Soto R; Henningsen RA; Martin RS; Hackos DH; Panicker S; Rubas W; Oglesby IB; Dillon MP; Milla ME; Burnstock G; Ford AP
Br J Pharmacol; 2010 Jul; 160(6):1387-98. PubMed ID: 20590629
[TBL] [Abstract][Full Text] [Related]
27. Selective Calcium-Dependent Inhibition of ATP-Gated P2X3 Receptors by Bisphosphonate-Induced Endogenous ATP Analog ApppI.
Ishchenko Y; Shakirzyanova A; Giniatullina R; Skorinkin A; Bart G; Turhanen P; Määttä JA; Mönkkönen J; Giniatullin R
J Pharmacol Exp Ther; 2017 Jun; 361(3):472-481. PubMed ID: 28404687
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of the P2X3 ATP receptor by PAR-2 in rat dorsal root ganglia neurons, through protein kinase-dependent mechanisms, contributes to inflammatory pain.
Wang S; Dai Y; Kobayashi K; Zhu W; Kogure Y; Yamanaka H; Wan Y; Zhang W; Noguchi K
Eur J Neurosci; 2012 Aug; 36(3):2293-301. PubMed ID: 22616675
[TBL] [Abstract][Full Text] [Related]
29. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
Soto F; Lambrecht G; Nickel P; Stühmer W; Busch AE
Neuropharmacology; 1999 Jan; 38(1):141-9. PubMed ID: 10193905
[TBL] [Abstract][Full Text] [Related]
30. DT-0111: a novel P2X3 receptor antagonist.
Pelleg A; Sirtori E; Rolland JF; Mahadevan A
Purinergic Signal; 2023 Sep; 19(3):467-479. PubMed ID: 36944825
[TBL] [Abstract][Full Text] [Related]
31. Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neurons.
Mo G; Peleshok JC; Cao CQ; Ribeiro-da-Silva A; Séguéla P
Mol Pharmacol; 2013 Mar; 83(3):640-7. PubMed ID: 23249537
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
[TBL] [Abstract][Full Text] [Related]
33. Changes in P2X receptor responses of sensory neurons from P2X3-deficient mice.
Zhong Y; Dunn PM; Bardini M; Ford AP; Cockayne DA; Burnstock G
Eur J Neurosci; 2001 Dec; 14(11):1784-92. PubMed ID: 11860473
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
El-Ajouz S; Ray D; Allsopp RC; Evans RJ
Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
[TBL] [Abstract][Full Text] [Related]
35. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
[TBL] [Abstract][Full Text] [Related]
36. Dioxotriazine derivatives as a new class of P2X
Kai H; Horiguchi T; Kameyama T; Asahi K; Endoh T; Jikihara S; Hasegawa T; Tanaka S; Nozu A; Takeyama C; Tomari M; Takahashi F; Tamura N; Yagi S; Itoh T; Isou Y
Bioorg Med Chem Lett; 2021 Apr; 37():127833. PubMed ID: 33540044
[TBL] [Abstract][Full Text] [Related]
37. 2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.
Dal Ben D; Marchenkova A; Thomas A; Lambertucci C; Spinaci A; Marucci G; Nistri A; Volpini R
Purinergic Signal; 2017 Mar; 13(1):61-74. PubMed ID: 27757785
[TBL] [Abstract][Full Text] [Related]
38. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
[TBL] [Abstract][Full Text] [Related]
39. [P2x3-receptor desensitization as an alternative mechanism of analgesia].
Petrenko NS; Kryshtal' OO
Fiziol Zh (1994); 2013; 59(2):104-10. PubMed ID: 23828978
[TBL] [Abstract][Full Text] [Related]
40. Cell type-specific ATP-activated responses in rat dorsal root ganglion neurons.
Ueno S; Tsuda M; Iwanaga T; Inoue K
Br J Pharmacol; 1999 Jan; 126(2):429-36. PubMed ID: 10077235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
